Isolating Functional (Iso)miRNA Targets During Ischemia

Overview

Journal Mol Ther

Publisher Cell Press

Specialties Molecular Biology
Pharmacology

Date 2019 Dec 25

PMID 31870621

Citations 1

Authors

Imo E Hoefer

Affiliations

Soon will be listed here.

Citing Articles

Aberration-corrected ultrafine analysis of miRNA reads at single-base resolution: a k-mer lattice approach.

Zhang X, Ping P, Hutvagner G, Blumenstein M, Li J Nucleic Acids Res. 2021; 49(18):e106.

PMID: 34291293 PMC: 8631080. DOI: 10.1093/nar/gkab610.

References

Welten S, de Jong R, Wezel A, de Vries M, Boonstra M, Parma L . Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis. Atherosclerosis. 2017; 261:26-36. DOI: 10.1016/j.atherosclerosis.2017.04.011. View

van der Kwast R, Woudenberg T, Quax P, Nossent A . MicroRNA-411 and Its 5'-IsomiR Have Distinct Targets and Functions and Are Differentially Regulated in the Vasculature under Ischemia. Mol Ther. 2019; 28(1):157-170. PMC: 6953895. DOI: 10.1016/j.ymthe.2019.10.002. View

Epstein S, Stabile E, Kinnaird T, Lee C, Clavijo L, Burnett M . Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. Circulation. 2004; 109(23):2826-31. DOI: 10.1161/01.CIR.0000132468.82942.F5. View

Welten S, Bastiaansen A, de Jong R, de Vries M, Peters E, Boonstra M . Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res. 2014; 115(8):696-708. DOI: 10.1161/CIRCRESAHA.114.304747. View

Seitz H, Royo H, Bortolin M, Lin S, Ferguson-Smith A, Cavaille J . A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004; 14(9):1741-8. PMC: 515320. DOI: 10.1101/gr.2743304. View

Telonis A, Magee R, Loher P, Chervoneva I, Londin E, Rigoutsos I . Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types. Nucleic Acids Res. 2017; 45(6):2973-2985. PMC: 5389567. DOI: 10.1093/nar/gkx082. View

Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A . A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. PMC: 2681231. DOI: 10.1016/j.cell.2007.04.040. View

Vogel J, Niederer D, Engeroff T, Vogt L, Troidl C, Schmitz-Rixen T . Effects on the Profile of Circulating miRNAs after Single Bouts of Resistance Training with and without Blood Flow Restriction-A Three-Arm, Randomized Crossover Trial. Int J Mol Sci. 2019; 20(13). PMC: 6651802. DOI: 10.3390/ijms20133249. View

Neilsen C, Goodall G, Bracken C . IsomiRs--the overlooked repertoire in the dynamic microRNAome. Trends Genet. 2012; 28(11):544-9. DOI: 10.1016/j.tig.2012.07.005. View

10.

Pankratz F, Bemtgen X, Zeiser R, Leonhardt F, Kreuzaler S, Hilgendorf I . MicroRNA-155 Exerts Cell-Specific Antiangiogenic but Proarteriogenic Effects During Adaptive Neovascularization. Circulation. 2015; 131(18):1575-89. DOI: 10.1161/CIRCULATIONAHA.114.014579. View

11.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View